Dr Ing Hc Stock Performance
| DRPRY Stock | 5.42 0.02 0.37% |
On a scale of 0 to 100, Dr Ing holds a performance score of 10. The firm owns a Beta (Systematic Risk) of 1.13, which means a somewhat significant risk relative to the market. Dr Ing returns are very sensitive to returns on the market. As the market goes up or down, Dr Ing is expected to follow. Please check Dr Ing's value at risk, and the relationship between the standard deviation and kurtosis , to make a quick decision on whether Dr Ing's current price history will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Ing hc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Dr Ing showed solid returns over the last few months and may actually be approaching a breakup point. ...more
DRPRY |
Dr Ing Relative Risk vs. Return Landscape
If you would invest 468.00 in Dr Ing hc on October 11, 2025 and sell it today you would earn a total of 74.00 from holding Dr Ing hc or generate 15.81% return on investment over 90 days. Dr Ing hc is currently producing 0.2591% returns and takes up 1.9217% volatility of returns over 90 trading days. Put another way, 17% of traded pink sheets are less volatile than DRPRY, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Dr Ing Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Ing's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Dr Ing hc, and traders can use it to determine the average amount a Dr Ing's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1348
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DRPRY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Dr Ing is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dr Ing by adding it to a well-diversified portfolio.
Dr Ing Fundamentals Growth
DRPRY Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Dr Ing, and Dr Ing fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DRPRY Pink Sheet performance.
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Revenue | 36.76 B | |||
| EBITDA | 9.38 B | |||
| Book Value Per Share | 25.19 X | |||
| Cash Flow From Operations | 6.42 B | |||
About Dr Ing Performance
Evaluating Dr Ing's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Dr Ing has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dr Ing has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Dr Ing hc performance evaluation
Checking the ongoing alerts about Dr Ing for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Dr Ing hc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Dr Ing's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Dr Ing's pink sheet performance include:- Analyzing Dr Ing's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dr Ing's stock is overvalued or undervalued compared to its peers.
- Examining Dr Ing's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dr Ing's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dr Ing's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dr Ing's pink sheet. These opinions can provide insight into Dr Ing's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for DRPRY Pink Sheet Analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.